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Abstract
Background: Excessive use of antibiotics is worldwide the most important reason for development of
antimicrobial resistance. As antibiotic resistance may spread across borders, high prevalence countries may serve as
a source of bacterial resistance for countries with a low prevalence. Therefore, bacterial resistance is an important
issue with a potential serious impact on all countries. Initiatives have been taken to improve the quality of
antibiotic prescribing in primary care, but only few studies have been designed to determine the effectiveness of
multifaceted strategies across countries with different practice setting. The aim of this study was to evaluate the
impact of a multifaceted intervention targeting general practitioners (GPs) and patients in six countries with
different health organization and different prevalence of antibiotic resistance.
Methods: GPs from two Nordic countries, two Baltic Countries and two Hispano-American countries registered
patients with respiratory tract infections (RTIs) in 2008 and 2009. After first registration they received individual
prescriber feedback and they were offered an intervention programme that included training courses, clinical
guidelines, posters for waiting rooms, patient brochures and access to point of care tests (Strep A and C-Reactive
Protein). Antibiotic prescribing rates were compared before and after the intervention.
Results: A total of 440 GPs registered 47011 consultations; 24436 before the intervention (2008) and 22575 after
the intervention (2009). After the intervention, the GPs significantly reduced the percentage of consultations
resulting in an antibiotic prescription. In patients with lower RTI the GPs in Lithuania reduced the prescribing rate
by 42%, in Russia by 25%, in Spain by 25%, and in Argentina by 9%. In patients with upper RTIs, the corresponding
reductions in the antibiotic prescribing rates were in Lithania 20%, in Russia 15%, in Spain 9%, and in Argentina 5%.
Conclusion: A multifaceted intervention programme targeting GPs and patients and focusing on improving
diagnostic procedures in patients with RTIs may lead to a marked reduction in antibiotic prescribing. The
pragmatic before-after design used may suffer from some limitations and the reduction in antibiotic prescribing
could be influenced by factors not related to the intervention.
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Excessive and inappropriate use of antibiotics is an
important reason for development of bacterial resistance
[1-3]. Countries with a high use of antibiotics have a
higher rate of resistance than countries with a low use
[4]. As antibiotic resistance may spread across borders,
high prevalence countries may serve as a source of bac-
terial resistance for countries with a low prevalence.
Therefore, bacterial resistance is an important issue with
a potentially serious impact on all countries.
Infections caused by resistant bacteria lead to
increased mortality, prolonged hospital stay and
increased costs [5,6]. A cornerstone of efforts to control
antibiotic resistance is to improve the quality of antibio-
tic prescribing in primary health care, as more than 90%
of antibiotics are prescribed by GPs. Approximately 70%
of antibiotics prescribed in general practice are for
respiratory tract infections (RTIs) [7,8]. However, the
majority of RTIs (90%) are caused by virus and in these
cases antibiotics are unlikely to have any clinical benefit.
Studies of the management of RTIs show that a consid-
erable number of antibiotic prescriptions are neither
necessary nor appropriate [9,10]. Most RTIs are harm-
less and self-limiting and nearly all patients recover
without any specific treatment. Antibiotic treatment
may thus be superfluous, and in some cases it may be
directly harmful due to adverse effects. Even if the
aetiology is bacterial, antibiotics only slightly modify
RTIs, particular in patients with upper RTIs [11,12].
Studies comparing bacterial resistance in various Eur-
opean countries have clearly documented that the preva-
lence of resistant strains is correlated with the
consumption of antibiotics [4,13]. Until recently, the
rates of antibiotic resistance in the northern European
countries have remained low. However, the rates of
resistance in the southern European countries are reach-
ing alarming levels. The different antibiotic prescribing
rates between countries may be due to discrepancies in
national recommendations, different health care systems,
different treatment traditions, different culture, different
patient expectations or different impact of marketing by
pharmacies and pharmaceutical companies. Several
initiatives have been taken to reduce the inappropriate
use of antibiotics in primary health care, but only few
have achieved positive results. According to a review
from the Cochrane Library, multifaceted interventions
seem to be more effective than singular interventions
[14]. However, only a few multifaceted interventions tar-
geting treatment of RTIs have been performed, and we
need information about the effect of multifaceted inter-
ventions in countries with different practice settings.
The aim of this study was to evaluate the impact of a
multifaceted intervention programme focusing on
appropriate antibiotic treatment of RTIs and targeting
general practitioners and patients in general practice.
The project was performed in six countries with differ-
ent primary health care settings of and different preva-
lence of antibiotic resistance.
Methods
Detailed information about the study method and the
intervention can be found in the study protocol, pub-
lished in BMC Family practice[15]. Briefly, data were
obtained from GPs in two Nordic countries (Denmark
and Sweden), two Baltic Countries (Lithuania and Rus-
sia) and two Hispano-American countries (Spain and
Argentina). Symptoms, signs, investigations, diagnosis,
assumed etiology and choice of treatment were regis-
tered for all patients with RTI during 3 weeks in the
winter months of 2008 and 2009. Patients were regis-
tered using a prospective self-registry methodology
based on a chart filled by the GP during the consulta-
tion [16].
Shortly after the first registration the GPs were invited
to follow-up meetings where they received individual
prescriber feedback and identified potential quality pro-
blems. Afterwards, they were offered an intervention
programme that included the following elements:
￿ Training course on appropriate use of antibiotics for
RTIs
￿ Clinical guidelines with recommendations for diag-
nosis and treatment of RTIs.
￿ Posters for waiting rooms, focusing on the appropri-
ate use of antibiotics
￿ Brochures and handouts to patients about prudent
use of antibiotics
￿ Access to Point of care (POC) tests: Strep A and C-
Reactive Protein (CRP)
￿ Training in use and interpretation of POC tests
After the intervention, the GPs performed the second
registration during a 3-week winter period one year
after the first registration. For each of the involved
countries we compared the antibiotic prescribing for
upper and lower RTIs before and after the intervention.
Furthermore, we investigated if the intervention had any
influence on the choice of antibiotic.
All patient registration data were treated confidentially
according to the law on protection of sensitive data and
the project was conducted in accordance with the EU
Directive of good clinical practice (EU Directive 2001/
20/EC).
Patients registered during the study were informed
about the objective of the project and they were told
that specific clinical information related to the consulta-
tion was entered into a multinational database. How-
ever, no electronic patient identifier was used; patients
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not contain any person-identifier or other information
that could be used to identify individual registry
patients. The study did not involve any randomization
of patients. The protocol was submitted to a legally con-
stituted ethics committee and deemed exempt from
review (The Scientific Ethical Committee for the County
of Vejle and Funen, Denmark)
Data were analyzed by the statistical program Stata,
version 11. We used 95% confidence intervals (CI),
adjusted for clustering to GPs.
Results
General practitoners
National coordinators from each of the participating
countries invited local GPs to participate by e-mail, tele-
phone or personal contact. The results presented in this
paper are based on data from GPs (n = 440) participat-
ing in both registration periods (2008 and 2009). The
GPs came from the following countries: Argentina (n =
48), Denmark (n = 78), Lithuania (n = 28), Russia (n =
37), Spain (210) and Sweden (39).
T a b l e1s h o w st h ec h a r a c t e r i s t i c so ft h eG P sp a r t i c i -
pating in the study. Median age of the GPs ranged from
41 years (Argentina) to 55 years (Denmark and Sweden).
In all countries, except Denmark and Sweden, the
majority of GPs were women. There was a great discre-
pancy in the median number of years the GPs had
worked in practice, ranging from 2 years (Russia) to 18
years (Spain). The majority of GPs worked in group
practices comprising more than four GPs. The median
number of patients listed per GP ranged from 1229
(Argentina) to 2272 (Russia). Workload, expressed by
the number of consultations per day, ranged from 10
(Sweden) to 40 (Spain) and correspondingly the median
number of minutes per consultation ranged from 6 min-
utes (Spain) to 20 minutes (Sweden).
Patients
A total of 47011 patients were registered; 24436 before
the intervention (2008) and 22575 after the intervention
(2009) (Table 2). The majority of patients were women.
The number of days with symptoms before contact to
the GPs ranged from 2 days (Argentina and Russia) to 6
days (Sweden).
Prescribing rates before and after intervention
Figure 1 shows the distribution of upper and lower RTIs
before and after the intervention. In all countries,
patients with upper RTIs represented the majority of
consultations. The rate of antibiotic prescribing was
highest for lower RTIs, but there were big differences in
prescribing rates between GPs from different countries
(Figures 2 and 3). Before the intervention, the highest
prescribing rates for lower RTIs were found in Lithua-
nia, where about nine out of ten consultations resulted
in an antibiotic prescription.
A significant reduction in the antibiotic prescribing
rate was found in the Baltic countries and Hispano-
America, while no significant change was seen in the
Nordic countries. For patients with lower RTIs, GPs
from Lithuania reduced their prescribing rate by 42%
(CI: 36%-47%), GPs from Russia by 25% (CI: 19%-30%),
GPs from Spain by 25% (CI: 22%-28%), and GPs from
Argentina by 9% (CI: 4%-14%). For patients with upper
RTIs, the antibiotic prescribing in Lithania was reduced
Table 1 Characteristics of the GPs
Country No
of
GPs
No of
women
(%)
Median
age
(iqr)
Median
number of
years (iqr)
working in
general
practice
Number of
GPs (%)
working in
single handed
practice
Median
number of GPs
(iqr) working
in group
practices
Median
number of
patients
(iqr) listed
per GP
Median
number of
working
hours per
day (iqr)
Median
number of
minutes
per cons
(iqr)
Median
number
of cons
per day
(iqr)
Argentina 48 32
(66)
41
(34-47)
9
(4-25)
24
(53)
3
(2-4)
1229
(450-3416)
6
(4-8)
15
(10-20)
20
(15-30)
Denmark 78 38
(49)
55
(45-59)
14
(5-22)
30
(38)
3
(2-4)
1300
(1229-1450)
8
(8-8)
15
(10-15)
25
(22-28)
Lithuania 28 23
(82)
48
(43-53)
7
(6-11)
3
(11)
4
(3-6)
1480
(893-1500)
6
(5-7)
15
(13-16)
25
(20-30)
Russia 37 32
(86)
52
(45-55)
2
(1-4)
12
(43)
4
(4-6)
2272
(1557-2916)
7
(7-8)
15
(12-18)
24
(20-25)
Spain 210 127
(62)
49
(44-52
18
(12-21)
12
(6)
13
(10-17)
1694
(1500-1923)
6
(5-7)
6
(5-7)
40
(35-45)
Sweden 39 18
(46)
55
(47-60)
17
(9-22)
0
(0)
6
(4-8)
1708
(1467-2098)
8
(7-8)
20
(20-20)
10
(9-12)
Total 440 270
(62)
50
(43-54)
15
(7-20)
81
(19)
8
(4-24)
1627
(1385-1886)
7
(5-8)
10
(6-15)
30
(21-40)
Bjerrum et al. BMC Family Practice 2011, 12:52
http://www.biomedcentral.com/1471-2296/12/52
Page 3 of 8by 20% (CI: 17%-23%), in Russia by 15% (CI: 13%-17%),
in Spain by 9% (CI: 7%-10%) and in Argentina by 5%
(CI: 3%-8%).
There were huge discrepancies between countries in
the choice of antibiotics for RTIs (Tables 3 and 4). In
patients with upper RTIs, GPs in the Nordic countries
preferred penicillin-V while GPs in Argentina, Lithuania,
Russia and Spain preferred amoxicillin. However, after
the intervention a considerable increase in the prescrib-
ing rate of penicillin-V for all patients with upper RTIs
was registered. In patients with lower RTIs, GPs in the
Nordic countries preferred penicillin-V while GPs in
Argentina, Lithuania, Russia and Spain preferred amoxi-
cillin or amoxicillin with clavulanic acid. The prescrib-
ing rate of tetracycline, quinolone, and cephalosporin
was generally low. However, in Sweden a considerable
part of patients with RTIs were treated with tetracy-
cline, in Spain with quinolone, and in Russia with
cephalosporin. In Denmark, many RTIs were treated
with macrolide, but a marked reduction was found after
the intervention.
Discussion
This study showed that a combined intervention pro-
gramme targeting GPs and patients and focusing on
improving diagnostic procedure and treatment in
patients with RTIs led to a marked reduction in antibio-
tic prescribing and a significant change in the choice of
antibiotics. A considerable reduction in antibiotic
Table 2 Characteristics of patients
Country 2008 2009
Number of
patients
registered
Percentage
of women
(95% CI)
Median
age
(iqr)
Median number of days
with symptoms before first
consultation (iqr)
Number of
patients
registered
Percentage
of women
(95% CI)
Median
age
(iqr)
Median number of days
with symptoms before first
consultation (iqr)
Argentina 3499 53
(51-55)
11
(3-29)
2
(2-3)
3641 53
(52-55)
20
(9-36)
2
(1-3)
Denmark 2881 59
(57-60)
25
(4-46)
4
(2-7)
3706 57
(56-59)
25
(4-47)
4
(3-7)
Lithuania 2517 54
(52-55)
14
(6-30)
3
(2-4)
1976 54
(52-56)
13
(4-26)
3
(2-4)
Russia 3591 54
(52-55)
25
(12-43)
2
(1-3)
3284 53
(52-55)
26
(13-46)
2
(2-3)
Spain 10909 59
(58-60)
43
(30-62)
3
(2-5)
9073 59
(58-60)
43
(29-62)
3
(2-5)
Sweden 1039 55
(52-58)
17
(4-47)
5
(3-10)
895 56
(53-59)
20
(3-47)
6
(3-10)
All 24436 57
(56-57)
32
(15-52)
3
(2-5)
22575 56
(56-57)
31
(15-52)
3
(2-5)
0%
25%
50%
75%
100%
2008 2009 . 2008 2009 . 2008 2009 . 2008 2009 . 2008 2009 . 2008 2009
Upper RTI Lower RTI Other RTI
% of consultations
Russia Argentina Sweden Spain Lithuania Denmark
Figure 1 Level of infection in patients with respiratory tract
infections (RTIs) in general practice before and after
intervention.
Figure 2 Prescription rate of antibiotics (% of consultations
resulting in an antibiotic prescription) in patients with upper
respiratory tract infections before and after the intervention.
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and Spain. In Denmark and Sweden we found no signif-
icant changes in the overall use of antibiotics, but
marked changes were found related to the choice of
antibiotics.
The intervention aimed to help GPs to distinguish
between viral and bacterial aetiology. All practices were
offered access to POC tests (StrepA and CRP) and the
practice staff was instructed how to interpret the results.
GPs were encouraged to employ a rational use of anti-
biotics according to the HAPPY AUDIT guidelines[15],
and they were requested only to prescribe antibiotics to
patients with a suspected bacterial aetiology.
All GPs were exposed to the multifaceted intervention
activities, and based on the results in this study it is not
possible to identify the elements that had the highest
impact on the prescibing pattern. The majority of GPs
(GPs from Argentina, Spain, Russia amd Lithuania) did
not have access to POC test before the intervention,
w h i l em o s tG P sf r o mt h eN o r d i cc o u n t r i e su s e dP O C
tests routinely. The marked effect of the intervention
f o u n do u t s i d et h eN o r d i cc o u n t r i e sm a yt oac e r t a i n
extent be due to the introduction of POC tests in
practice.
Our data must, however, be interpreted with caution
due to a number of limitations. GPs participated on a
voluntary basis and probably their prescribing habits
may not represent the average use of antibiotics in their
country [17]. GPs that were willing to register their anti-
biotic prescribing may have been more interested in
quality development and research than GPs in general.
Figure 3 Prescription rate of antibiotics (% of consultations
resulting in an antibiotic prescription) in patients with lower
respiratory tract infections before and after the intervention.
Table 3 Choice of antibiotic (%) in patients with upper respiratory tract infections before and after the intervention
Before intervention (95% CI)*
Penicillin-V Amoxicillin Amoxicillin-Clavulanic acid Macrolide Quinolone Tetracycline Cephalosporin Other
Argentina 15.3
(8.2-22.4)
54.7
(38.3-71.1)
16.9
(5.0-28.8)
2.3
(0.7-4.5)
1.5
(0-3.0)
0.1
(0-0.4)
4.1
(0-8.5)
10.0
(0-21.1)
Denmark 79.6
(74.0-85.3)
9.2
(5.9-12.6)
0.2
(0-0.5)
7.2
(4.7-9.8)
0.2
(0-0.5)
0.2
(0-0.5)
0
(0-0)
3.9
(0.3-7.5)
Lithuania 24.2
(16.7-31.8)
37.6
(26.0-49.1)
18.1
(13.3-22.8)
6.5
(4.2-8.9)
0
(0-0)
1.8
(0-3.8)
10.9
(4.5-17.4)
0.8
(0-1.6)
Russia 9.0
(3.4-14.6)
42.5
(31.3-53.8)
29.2
(18.6-39.8)
14.1
(5.8-22.3)
1.9
(0-4.0)
1.4
(0-4.0)
1.8
(0.6-2.9)
0.5
(0-1.0)
Spain 10.1
(7.1-13.2)
34.8
(30.2-39.4)
32.2
(27.6-36.7)
9.0
(6.2-11.9)
1.8
(0.9-2.8)
0.1
(0-0.2)
3.8
(2.6-5.1)
8.8
(3.3-14.4)
Sweden 78.1
(70.6-85.5)
6.8
(3.5-10.2)
0
(0-0)
2.9
(0.7-5.1)
0
(0-0)
6.8
(0.3-11.0)
2.1
(0.1-4.2)
3.2
(0.9-5.6)
After intervention
(95% CI)*
Argentina 31.2
(22.6-39.8)
40.1
(26.6-53.6)
8.1
(3.5-12.7)
2.0
(0-4.2)
0.5
(0-1.2)
0.3
(0-1.0)
0.5
(0-1.2)
22.4
(7.2-37.7)
Denmark 83.7
(79.4-87.9)
10.0
(6.2-13.9)
2.0
(0.2-3.9)
3.0
(1.7-4.5)
0.3
(0-0.8)
0
(0-0)
0
(0-0)
1.2
(0.1-2.2)
Lithuania 68.5
(58.5-78.6)
17.6
(8.4-26.8)
2.8
(1.2-4.3)
7.9
(4.0-11.7)
0
(0-0)
0.5
(0-1.4)
0.5
(0-1.4)
2.3
(0-6.1)
Russia 19.4
(8.8-30.1)
55.0
(43.5-66.4)
12.8
(5.2-20.4)
5.7
(0-12.5)
0
(0-0)
0.9
(0-2.1)
4.3
(0.7-7.8)
1.9
(0-4.5)
Spain 31.0
(26.2-35.9)
29.8
(25.0-34.5)
26.4
(22.0-30.7)
4.7
(2.9-6.4)
1.7
(0.7-2.6)
0
(0-0)
2.7
(1.3-4.1)
4.1
(1.1-7.2)
Sweden 75.9
(70.2-81.7)
7.1
(3.7-10.7)
1.2
(0-2.7)
3.8
(1.3-6.3)
0
(0-0)
6.7
(3.4-10.1)
2.5
(0.5-4.6)
2.9
(1.1-4.8)
*: Adjusted for clustering to GPs
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Page 5 of 8Table 4 Choice of antibiotic (%) in patients with lower respiratory tract infections before and after the intervention
Before intervention (95% CI)*
Penicillin-V Amoxicillin Amoxicillin-Clavulanic
acid
Macrolide Quinolone Tetracycline Cephalosporin Other
Argentina 4.2
(1.6-6.9)
52.6
(38.6-66.7)
24.5
(13.8-35.2)
9.7
(5.5-14.0)
1.6
(0-3.5)
0
(0-0)
4.6
(1.1-8.2)
10.3
(1.3-19.3)
Denmark 60.0
(55.3-65.7)
13.6
(10.0-17.2)
1.3
(0-2.9)
23.1
(17.6-28.5)
0.8
(0-1.8)
1.0
(0-2.4)
0
(0-0)
0.8
(0-1.6)
Lithuania 6.9
(1.7-12.2)
33.4
(21.9-44.9)
25.4
(17.3-33.5)
19.7
(14.8-24.7)
1.7
(0.3-3.1)
1.8
(0.3-3.5)
10.7
(3.6-17.9)
1.3
(0-2.6)
Russia 4.7
(0.4-9.1)
33.7
(24.1-43.4)
28.0
(17.1-38.9)
13.8
(5.8-21.7)
4.7
(0-9.5)
0.4
(0-1.0)
20.2
(13.1-27.2)
0.8
(0-1.7)
Spain 0.2
(0-0.5)
19.3
(15.8-22.8)
44.9
(40.7-49.1)
13.5
(10.6-16.4)
16.0
(12.9-19.1)
0.4
(0-0.9)
3.6
(2.3-5.0)
2.5
(0.6-4.3)
Sweden 30.1
(19.2-40.9)
14.2
(8.0-20.3)
0
(0-0)
6.2
(1.9-10.4)
0
(0-0)
48.7
(39.1-58.3)
1.8
(0-4.1)
0
(0-0)
After intervention
(95% CI)*
Argentina 3.3
(0.5-6.2)
35.5
(26.3-44.6)
34.6
(25.4-43.8)
19.4
(9.8-29.0)
2.4
(0-5.3)
0.9
(0-1.8)
4.9
(0.4-9.4)
21.4
(2.0-40.9)
Denmark 70.7
(65.7-75.8)
10.8
(6.7-14.9)
6.2
(3.4-9.0)
11.1
(8.2-14.1)
0
(0-0)
0.2
(0-0.5)
0
(0-0)
0.9
(0-1.8)
Lithuania 38.1
(25.1-51.0)
22.9
(13.8-32.1)
6.1
(0.2-12.0)
22.1
(14.3-29.9)
0
(0-0)
3.0
(0.9-5.2)
5.2
(2.0-8.4)
3.4
(0-7.7)
Russia 10.7
(1.8-19.4)
47.9
(35.0-60.7)
17.9
(8.1-27.8)
6.4
(1.9-10.9)
2.5
(0-5.2)
0
(0-0)
15.8
(6.7-24.9)
0.4
(0-1.3)
Spain 0.5
(0-1.0)
22.5
(18.0-27.0)
42.8
(37.7-48.0)
12.9
(9.7-16.0)
16.1
(12.7-19.4)
0
(0-0)
3.9
(2.0-5.9)
1.8
(0.9-2.8)
Sweden 43.5
(29.8-57.3)
10.6
(3.3-17.9)
0
(0-0)
5.9
(1.5-10.2)
0
(0-0)
37.6
(23.5-51.8)
0
(0-0)
2.3
(0-5.6)
*: Adjusted for clustering to GPs
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8Furthermore, they were willing to dedicate sufficient
time to complete patient reports without economic
incentives. The amount of time involved in this project
could be considered to be a prominent barrier to parti-
cipation, as GPs might find it difficult to dedicate the
time in their daily work. However, earlier studies using
t h es a m et y p eo fd a t ar e g i s t r a t i o nd i dn o tf i n di tv e r y
time-consuming. Each registration takes less than 2
minutes, but the GPs also needed to allocate sufficient
time for the subsequent courses and other activities
planned during the intervention period.
Another limitation which should be taken into
account is the fact that performing a registration on
antibiotic use may in itself influence the prescribing
habits. However, studies have shown that the reliability
of this methodology applied in different countries is
high and findings are correlated with the real prescrib-
ing in practice [16].
In our study, we asked the GPs to register what hap-
pened during the consultation, but patients were not
followed after the consultation and thus we have no
knowledge about the consequence of reducing antibiotic
prescribing for the patients involved. From a theoretical
point of view, the decision to treat should be taken after
a diagnosis has been established. In general practice,
however, the diagnostic procedures and the decision to
treat are intricately linked. The GP may decide whether
or not to prescribe an antibiotic at the same time, or
even before, he classifies a specific diagnosis to the
patient. After making the decision to prescribe the GP
may thus adjust the diagnosis to fit the decision about
treatment. This may lead to a diagnostic misclassifica-
tion bias. However, this potential bias will affect the
validity of the diagnosis both before and after the inter-
vention and it only has a small likelihood of influencing
the effect of the intervention.
Due to the limited time allocated for the registration
process in practice only the typical signs and symptoms of
RTIs according to the medical literature were recorded.
This may lead to some limitations. The before-after design
without a control group suffers from some limitations due
to the fact that changes in antibiotic prescribing could be
due to factors other than the intervention performed by
the investigators. Non-biomedical factors that might
represent powerful predictors of antibiotic prescription
such as market regulation and socio-economic factors
were not taken into account in this study.
This is a pragmatic study where registration of
patients was performed in a natural practice setting.
Patients were not informed about the project prior to
the consultations. GPs participating in the audit were
not allocated extra time for consultations, and they were
not able to make considerable changes in their practice
activities during the 3 weeks of registration. Thus, they
a t t e n d e dt h es a m ep a t i e n t sa si ft h e yw e r en o tp a r t i c i -
pating in the study. Therefore, it is most likely that our
results can be extrapolated to other areas and practices
with similar settings.
Conclusion
We found that a combined intervention programme
targeting GPs and patients and focusing on improving
diagnostic procedures in patients with RTIs led to a
marked reduction in antibiotic prescribing. The prag-
matic before-after design without control group suf-
fers from some limitations due to the fact that
changes in antibiotic prescribing could be influenced
by factors not related to the intervention. All GPs
were exposed to the multifaceted intervtention activ-
ities, and it is not possible to identify which of the
elements that had highest impact on the prescribing
pattern.
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